Nakamoto Inc. CFO Buys 17.8 M Shares—Insider Confidence Amid Bitcoin‑Health Care Pivot

Insider Buying Surge at Nakamoto Inc.

The latest Form 4/A from Chief Investment Officer Evans Tyler Matthew shows a sizable purchase of 17.84 million shares on February 20, 2026—about 2.9 % of the company’s diluted share count. The trade was executed at the market price of $0.26, a level that has held steady in recent weeks. While the transaction appears routine, its timing and scale warrant closer scrutiny given the broader context of insider activity and the company’s recent structural changes.

Implications for Investors and the Company’s Trajectory

Matthew’s purchase, coupled with simultaneous acquisitions of over 25 million vested stock options, signals confidence in Nakamoto’s long‑term value proposition. The company has recently rebranded from Kindly MD, Inc. to Nakamoto Inc., and its focus on Bitcoin‑native infrastructure positions it at the intersection of health‑care and blockchain technology. However, the stock’s performance—down 82 % year‑to‑date and trading near a 52‑week low—highlights volatility. Insider buying can serve as a counterbalance, suggesting that senior management believes the current valuation undervalues future upside, especially as the firm scales its crypto‑asset platform.

A Profile of Evans Tyler Matthew

Matthew’s transaction history is characterized by large, non‑cash purchases. Since the merger in February, he has accumulated roughly 20 million shares and 25 million vested options, with a total position exceeding 45 million securities. His buying pattern aligns with a long‑term investment thesis rather than short‑term speculation. Historically, Matthew has favored bulk acquisitions at flat or low prices, often following significant corporate events (mergers, restructurings). This disciplined approach may reassure investors that the CFO’s portfolio reflects genuine conviction in Nakamoto’s business model.

What This Means for the Future

For investors, Matthew’s activity offers a modest quality signal amid a bearish market. It suggests that senior executives anticipate a rebound once the company’s blockchain initiatives mature and the broader crypto market stabilizes. Yet, the negative earnings ratio and steep year‑to‑date decline imply that short‑term catalysts are still uncertain. Monitoring future insider trades—especially any shift toward option sales or large divestitures—will be crucial to gauge whether management’s optimism persists.

Conclusion

Evans Tyler Matthew’s recent bulk purchase and option accumulation reinforce a narrative of insider confidence in Nakamoto Inc.’s transformative strategy. While the stock remains fragile, the CFO’s substantial stake may provide a stabilizing anchor for long‑term investors who believe in the company’s unique position at the crossroads of health care and blockchain innovation.